Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Hormones, Cognition and Dementia: State of the Art and Emergent Therapeutic Strategies

Hormones, Cognition and Dementia: State of the Art and Emergent Therapeutic Strategies

9780521899376
566.94 zł
510.24 zł Save 56.70 zł Tax included
Lowest price within 30 days before promotion: 510.24 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
A decade ago, oestrogen-containing hormone therapy was viewed as a promising strategy for the prevention and treatment of dementia and age-related cognitive decline. However, treatment trials in women with Alzheimers disease showed that oestrogens did not reverse cognitive impairment, and clinical trials in healthy older women indicated that oestrogens did not prevent cognitive decline. The Womens Health Initiative Memory Study trial even suggested an increased risk of dementia with treatment late in life. What happened? How are we to understand these findings? What are the implications for middle-aged and older women? What about testosterone, and what about men? And where do we go from here? This book brings together world-renowned experts in basic and clinical research on sex steroids, aging, and cognition to integrate existing findings with emerging new data, and offer challenging hypotheses on these key issues.
Product Details
Cambridge University Press
97895
9780521899376
9780521899376

Data sheet

Publication date
2009
Issue number
1
Cover
hard cover
Pages count
292
Dimensions (mm)
192.00 x 252.00
Weight (g)
800
  • Preface; Part I. Estrogens and Cognition:: 1. Womens Health Initiative Memory Study (WHIMS) program; 2. Identifying risk-factors for cognitive change in the Womens Health Initiative; 3. Estrogen therapy - relationship to longevity and prevalent dementia in the oldest-old; 4. The critical window hypothesis:: hormone exposures and cognitive outcomes after menopause; 5. Animal studies that support estrogen effects on cognitive performance and the cholinergic basis of the critical period hypothesis; Part II. Varieties of Estrogenic Therapy:: 6. The healthy cell bias of estrogen action through regulating glucose metabolism and mitochondrial function; 7. Alternative estrogenic treatment regimes and the Kronos Early Estrogen Prevention Study-Cognitive and Affective Substudy (KEEPS-CA); 8. The use of transdermal 17-estradiol in the treatment of Alzheimers disease; 9. Alternative modes of treatment:: pulsatile estradiol treatment; 10. In search of estrogen alternatives for the brain; Part III. Potential Modulators and Modifiers of Estrogenic Effects:: 11. Progesterone regulation of neuroprotective estrogen actions; 12. Clinical data of estrogens effects in the central nervous system; 13. Different forms of soy processing may determine the positive or negative impact on cognitive function of Indonesian elderly; 14. Hypothalamus-pituitary-adrenal axis activity in aging women; Part IV. Possible Genetic Factors Related to Hormone Treatment Effects:: 15. Possible genetic polymorphisms related to sex steroid metabolism and dementia in women; 16. Genetics related to sex steroids:: implications for Alzheimers disease; 17. Apolipoprotein E, hormone therapy and neuroprotection; 18. Testosterone, gonadotrophins and genetic polymorphisms in men with Alzheimers disease; Part V. Testosterone, Estradiol and Men, and Sex Hormone Binding Globulin:: 19. Androgens and cognitive functioning in women; 20. The role of estradiol in testosterone treatment; 21. Endogenous testosterone levels and cognitive aging in men; 22. Clinical trials and neuroimaging studies of testosterone in men:: insights into effects on verbal memory; 23. Testosterone therapy and Alzheimers disease:: potential for treatment and prevention in women; 24. Endogenous estradiol and dementia in elderly men:: the roles of vascular risk, sex hormone binding globulin, and aromatase activity; 25. Testosterone regulates Alzheimers disease pathogenesis; Part VI. Gonadotropin Effects:: 26. Involvement of gonadotropins in cognitive function:: implications for Alzheimers disease; 27. The role of gonadotropins and testosterone in the regulation of beta amyloid metabolism; 28. Epilogue; 29. Concluding remarks; Index.
Comments (0)

  • Frequently purchased together

    No products available